Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Sareum Holdings ( (GB:SAR) ) is now available.
Sareum Holdings PLC has successfully raised £1.07 million through an institutional equity fundraise by issuing 8,560,000 new ordinary shares at a price of 12.5 pence each, which is a 24% discount to the previous day’s closing price. The funds will be used to support the development of Sareum’s expanded portfolio, including SRA737, and for general working capital, potentially enhancing the company’s market position and shareholder value.
More about Sareum Holdings
Sareum Holdings PLC is a clinical-stage biotechnology company based in Cambridge, UK. It specializes in developing next-generation kinase inhibitors aimed at treating autoimmune diseases and cancer.
YTD Price Performance: -32.65%
Average Trading Volume: 180,726
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £20.61M
For an in-depth examination of SAR stock, go to TipRanks’ Stock Analysis page.